Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19

This paper provides an overview of the current global market and manufacturing landscape for hydroxychloroquine (HCQ). The capacity and capabilities of global producers to meet the potential demand for treating patients inflicted with COVID-19 by the novel corona virus SARS-CoV-2, should HCQ's...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tony Y., Zhong, Boyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144509/
https://www.ncbi.nlm.nih.gov/pubmed/32292908
http://dx.doi.org/10.1016/j.medidd.2020.100036
_version_ 1783519847241482240
author Zhang, Tony Y.
Zhong, Boyu
author_facet Zhang, Tony Y.
Zhong, Boyu
author_sort Zhang, Tony Y.
collection PubMed
description This paper provides an overview of the current global market and manufacturing landscape for hydroxychloroquine (HCQ). The capacity and capabilities of global producers to meet the potential demand for treating patients inflicted with COVID-19 by the novel corona virus SARS-CoV-2, should HCQ's efficacy be established by more definitive clinical trials, is also assessed. Given the large existing manufacturing base and abundance of raw materials for HCQ, the supply challenge can be met with considerable efforts and international cooperation. Preemptive and coordinated emergency efforts among global governments, regulatory agencies, chemical and pharmaceutical industries are imperative for meeting the potential surge in demand.
format Online
Article
Text
id pubmed-7144509
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71445092020-04-09 Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19 Zhang, Tony Y. Zhong, Boyu Med Drug Discov Article This paper provides an overview of the current global market and manufacturing landscape for hydroxychloroquine (HCQ). The capacity and capabilities of global producers to meet the potential demand for treating patients inflicted with COVID-19 by the novel corona virus SARS-CoV-2, should HCQ's efficacy be established by more definitive clinical trials, is also assessed. Given the large existing manufacturing base and abundance of raw materials for HCQ, the supply challenge can be met with considerable efforts and international cooperation. Preemptive and coordinated emergency efforts among global governments, regulatory agencies, chemical and pharmaceutical industries are imperative for meeting the potential surge in demand. The Author(s). Published by Elsevier B.V. 2020-03 2020-04-09 /pmc/articles/PMC7144509/ /pubmed/32292908 http://dx.doi.org/10.1016/j.medidd.2020.100036 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhang, Tony Y.
Zhong, Boyu
Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19
title Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19
title_full Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19
title_fullStr Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19
title_full_unstemmed Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19
title_short Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19
title_sort meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144509/
https://www.ncbi.nlm.nih.gov/pubmed/32292908
http://dx.doi.org/10.1016/j.medidd.2020.100036
work_keys_str_mv AT zhangtonyy meetingthepotentialemergencyglobaldrugsupplychallengeofhydroxychloroquineforcovid19
AT zhongboyu meetingthepotentialemergencyglobaldrugsupplychallengeofhydroxychloroquineforcovid19

Ejemplares similares